Kyle Jenne
Analyst
Equibles does not estimate personal net worth.
About Kyle Jenne
Kyle Jenne has spoken on 2 earnings calls across 1 company, most recently for Ionis Pharmaceuticals Inc on July 29, 2026. The companies whose calls Kyle Jenne spoke on are classified in the Healthcare sector.
Kyle Jenne on recent calls
“Our commercial momentum continues to build, positioning us to deliver even greater impact in the second half of the year and beyond. We are executing well against our commercial priorities, including strong progress on the Tringolza and Donzera launches and preparation for the Zulganersen launch.”
“With a strong first year for Tringolza, an encouraging start for Donzera, and two more anticipated independent launches this year, our commercial team remains focused on flawless execution to continue bringing our important medicines to patients.”